Regression of Crizotinib-Associated Complex Cystic Lesions after Switching to Alectinib
Sign Up to like & getrecommendations! Published in 2017 at "Internal Medicine"
DOI: 10.2169/internalmedicine.8445-16
Abstract: Crizotinib, which is effective in patients with anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer, is sometimes associated with the generation of complex renal cysts. A 56-year-old man with ALK positive adenocarcinoma received crizotinib.… read more here.
Keywords: associated complex; crizotinib associated; switching alectinib; crizotinib ... See more keywords